Oz’s Embrace Of Alternative Medicine Could Influence CMS Policy

President-elect Donald Trump’s proposed appointment of physician and TV personality Mehmet Oz to lead CMS could have an impact on the agency’s coverage policies toward unproven treatments not tested by FDA, as well as Medicare’s controversial coverage determinations on FDA-approved drugs for which CMS has required continued evidence collection. Trump announced the choice of Oz, who ran for Senate as a Republican in 2022 and has a long history as a television host on medical issues, Tuesday (Nov. 19). Trump...